Corporate Profile

<< Back
Over 45 million people in the U.S. have a substance use, addictive, or eating disorder. The National Institute on Drug Abuse (NIDA), a division of the National Institutes of Health (NIH), describes these disorders as chronic relapsing brain diseases, which burden society at both the individual and community levels. Opiant is a specialty pharmaceutical company developing treatments for substance use, addictive, and eating disorders.
Print Page E-mail Page RSS Feeds E-mail Alerts IR Contacts Financial Tear Sheet